Treatment of In-Stent Restenosis by Combining Cutting Balloon Angioplasty and Intravascular Brachytherapy
叶飞,陈绍良,段宝祥,宋杰,马玉玲,林松,贾海波,耿其吉,刘玲玲,常芸
DOI: https://doi.org/10.3969/j.issn.0253-3685.2002.10.001
2002-01-01
Abstract:Objective To investigate the clinical value of treatment of in stent restenosis (ISR) by combining cutting balloon angioplasty (CBA) and intravascular brachytherapy (IVBT).Methods 36 patients with ISR confirmed by coronary angiogram (CAG) average 6 7 months after first stenting were divided into CBA+IVBT group (Group 1,with 20 cases)which were treated by a 10mm long cutting balloon with ratio of diameter and conference vessel were 1 1∶1,and plain old balloon angioplasty(POBA)+IVBT group (Group 2,with 16 cases)which were treated by a plain old balloon firstly,and then radiation therapy were used with a 40mm long radiation catheter covering the whole lesion.Minimal lumen diameter (MLD)and acute gain (AG)were checked by CAG.The primary end point included death,myocardial infarction and target vessel revasculrization.Procedural parameters included MLD,AG,late loss (LL),ratio of restenosis (RRS) and loss index (LI)were determined during follow up after first PCI 4~8 months.Results During follow up,there was a significant advantage in terms of major adverse events for Group 1 [10% versus 18 8% for Group 2 ( P 0 05)],and LL,LI,MAE and RRS for Group 1 were significantly lower than that for Group 2[(0 16±0 27mm,0 05±0 01,10%,15% versus 0 32±0 31mm,0 11±0 02,43 8%,37 5%( P 0 05)).[WTHZ]Conclusion These results show that the feasibility and safety of the strategy of combining cutting balloon angioplasty followed by IVBT.They demonstrated additional clinical benefit at 4~8 months follow up with this strategy compared to conventional PTCA and IVBT.
What problem does this paper attempt to address?